X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (134) 134
hematology (114) 114
index medicus (112) 112
transplantation (105) 105
adult (99) 99
female (99) 99
middle aged (95) 95
male (80) 80
aged (72) 72
oncology (68) 68
stem cells (62) 62
hematology, oncology and palliative medicine (59) 59
article (50) 50
immunology (48) 48
antineoplastic combined chemotherapy protocols - therapeutic use (43) 43
hematopoietic stem cell transplantation (43) 43
cancer (41) 41
chemotherapy (40) 40
young adult (40) 40
treatment outcome (37) 37
adolescent (36) 36
hematopoietic stem cells (33) 33
retrospective studies (33) 33
high-dose chemotherapy (32) 32
multiple myeloma (32) 32
stem-cell transplantation (32) 32
survival (32) 32
transplantation, autologous (31) 31
lymphomas (30) 30
disease-free survival (29) 29
bone-marrow-transplantation (28) 28
survival analysis (28) 28
prognosis (27) 27
care and treatment (26) 26
melphalan (26) 26
analysis (23) 23
busulfan (23) 23
hematopoietic stem cell transplantation - methods (23) 23
therapy (23) 23
relapse (21) 21
combined modality therapy (20) 20
transplantation conditioning - methods (20) 20
recurrence (19) 19
autografts (18) 18
child (18) 18
deoxycytidine - analogs & derivatives (18) 18
stem cell transplantation (18) 18
breast neoplasms - drug therapy (17) 17
cyclophosphamide (17) 17
gemcitabine (17) 17
prospective studies (17) 17
survival rate (17) 17
multiple myeloma - therapy (16) 16
patient outcomes (16) 16
transplantation, homologous (16) 16
breast neoplasms - pathology (15) 15
leukemia (15) 15
lymphoma (15) 15
melphalan - administration & dosage (15) 15
antineoplastic combined chemotherapy protocols - administration & dosage (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
breast neoplasms - therapy (14) 14
disease (14) 14
dose-response relationship, drug (14) 14
fludarabine (14) 14
hematopoietic stem cell transplantation - adverse effects (14) 14
mortality (14) 14
myeloma (14) 14
abridged index medicus (13) 13
bone marrow (13) 13
bone-marrow (13) 13
busulfan - administration & dosage (13) 13
hematologic neoplasms - therapy (13) 13
patients (13) 13
randomized-trial (13) 13
antineoplastic agents - therapeutic use (12) 12
breast neoplasms - mortality (12) 12
deoxycytidine - administration & dosage (12) 12
dosage and administration (12) 12
follow-up studies (12) 12
risk factors (12) 12
time factors (12) 12
usage (12) 12
vidarabine - analogs & derivatives (12) 12
bortezomib (11) 11
cyclophosphamide - administration & dosage (11) 11
hemic and lymphatic diseases (11) 11
hodgkin disease - therapy (11) 11
antineoplastic agents - administration & dosage (10) 10
autologous transplantation (10) 10
diseases (10) 10
graft vs host disease - etiology (10) 10
hematologic neoplasms - mortality (10) 10
neoplasm staging (10) 10
radiotherapy (10) 10
risk (10) 10
versus-host-disease (10) 10
acute myeloid-leukemia (9) 9
carmustine - administration & dosage (9) 9
child, preschool (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 09/2016, Volume 126, Issue 9, pp. 3363 - 3376
BACKGROUND. T cells expressing antigen-specific chimeric antigen receptors (CARs) improve outcomes for CD19-expressing B cell malignancies. We evaluated a... 
MEDICINE, RESEARCH & EXPERIMENTAL | CLINICAL-TRIAL | BONE-MARROW-TRANSPLANTATION | CHIMERIC-ANTIGEN-RECEPTOR | ACUTE LYMPHOBLASTIC-LEUKEMIA | NON-HODGKIN-LYMPHOMA | VERSUS-HOST-DISEASE | MINIMAL RESIDUAL DISEASE | HEMATOLOGIC MALIGNANCIES | ADOPTIVE IMMUNOTHERAPY | ANTITUMOR EFFICACY | Immunotherapy, Adoptive - methods | Cytokines - metabolism | Follow-Up Studies | Receptors, Antigen, T-Cell - metabolism | Humans | Middle Aged | Hematopoietic Stem Cell Transplantation | Male | Treatment Outcome | Antigen-Presenting Cells - immunology | Plasmids - metabolism | DNA Transposable Elements | Transplantation, Homologous | Young Adult | Disease-Free Survival | Lymphocyte Activation - immunology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | T-Lymphocytes - cytology | Lymphoma, Non-Hodgkin - therapy | Patient Safety | Adult | Female | Antigens, CD19 - metabolism | Genetic Therapy - methods | Cell receptors | Transplantation | Genetic aspects | Health aspects | Patient outcomes | Hematopoietic stem cells | Medical research | Cytokines | Genes | Cloning | Leukemia | Clinical trials | Principal components analysis | T cell receptors | Cancer therapies | Studies | Plasmids | Lymphocytes | Immunotherapy | Genetic engineering | Lymphomas | Design of experiments | Deoxyribonucleic acid--DNA | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 24, pp. 2305 - 2315
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2017, Volume 177, Issue 4, pp. 567 - 577
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2017, Volume 177, Issue 3, pp. 457 - 466
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 1, pp. 175 - 182
Purpose Few studies to date have evaluated factors associated with the development of radiation pneumonitis (RP) in patients with Hodgkin lymphoma (HL) and... 
Radiology | Hematology, Oncology and Palliative Medicine | CELL LUNG-CANCER | VOLUME HISTOGRAM ANALYSIS | IRRADIATION | PULMONARY TOXICITY | ONCOLOGY | DISEASE | INSPIRATION BREATH-HOLD | HIGH-DOSE CHEMOTHERAPY | RADIOTHERAPY | ONCOLOGY GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | TRANSPLANTATION | Doxorubicin - therapeutic use | Salvage Therapy - adverse effects | Radiation Pneumonitis - etiology | Dacarbazine - therapeutic use | Radiotherapy Planning, Computer-Assisted - methods | Humans | Middle Aged | Male | Vinblastine - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Young Adult | Hodgkin Disease - radiotherapy | Mediastinal Neoplasms - drug therapy | Bleomycin - therapeutic use | Hematopoietic Stem Cell Transplantation - adverse effects | Hodgkin Disease - drug therapy | Adult | Female | Lung - radiation effects | Retrospective Studies | Lymphoma, Non-Hodgkin - drug therapy | Radiotherapy Dosage | Regression Analysis | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - radiotherapy | Adolescent | Salvage Therapy - methods | Care and treatment | Pneumonia | Chemotherapy | Bacterial pneumonia | Stem cells | Radiation | Lymphomas | Radiotherapy | Cancer | Index Medicus | REVIEWS | DIAGNOSIS | PATIENTS | LUNGS | RADIATION DOSES | TOXICITY | CHEMOTHERAPY | LYMPHOMAS | MULTIVARIATE ANALYSIS | MEDIASTINUM | RADIOLOGY AND NUCLEAR MEDICINE | PNEUMONITIS | STEM CELLS | HAZARDS
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2017, Volume 176, Issue 5, pp. 750 - 758
Journal Article
Cancer, ISSN 0008-543X, 08/2017, Volume 123, Issue 16, pp. 3141 - 3149
Journal Article
Experimental hematology, ISSN 0301-472X, 01/2020
Gemcitabine (Gem), busulfan (Bu) and melphalan (Mel) are used for hematopoietic stem cell transplantation (HSCT). To further improve their efficacy, a... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2006, Volume 24, Issue 18, pp. 2910 - 2916
Purpose The American Joint Committee on Cancer staging system for breast cancer was recently updated to reflect the impact of increasing the absolute number of... 
AMERICAN-JOINT-COMMITTEE | SURVIVAL | ONCOLOGY | DISSECTION | LYMPH-NODES | POSTOPERATIVE RADIOTHERAPY | RISK | RECURRENCE | HIGH-DOSE CHEMOTHERAPY | NON-SENTINEL NODE | STEM-CELL TRANSPLANTATION | Breast Neoplasms - mortality | Lymphatic Metastasis | Prognosis | Breast Neoplasms - pathology | Humans
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 2018, Volume 54, Issue 7, pp. 1089 - 1093
Primary plasma cell leukemia (pPCL) is a rare and aggressive variant of multiple myeloma (MM) with poor long-term survival after cytotoxic chemotherapy. Many... 
SURVIVAL | DEXAMETHASONE | CONSOLIDATION | ONCOLOGY | LENALIDOMIDE | BORTEZOMIB | IMMUNOLOGY | HEMATOLOGY | MYELOMA | TRANSPLANTATION | Medical colleges | Chemotherapy | Leukemia | Stem cells | Carfilzomib | Transplantation | Vincristine | Cancer | Drugs | Autografts | Algorithms | Transplants & implants | Multiple myeloma | Plasma cell leukemia | Cytotoxicity
Journal Article